Shelf life – Page 39

How to Prevent Stability Data Integrity Issues During Study Design

Mitigating Issues Related to Stability Study Design In the landscape of pharmaceutical manufacturing, integrity issues during stability study design can lead to significant regulatory scrutiny and jeopardize product approvals. This…

Regulatory Expectations for Stability Data Integrity and Audit Trails

Addressing Challenges with Data Integrity in Stability Studies: Ensuring Compliance with Regulatory Expectations In the pharmaceutical industry, maintaining the integrity of stability data is critical for ensuring compliance with regulatory…

Photostability Study Failures Caused by Poor Analytical Specificity

Addressing Photostability Study Failures Due to Insufficient Analytical Specificity In the realm of pharmaceutical stability studies, photostability assessments play a crucial role in determining how light exposure impacts drug quality,…

Stability Protocol Gaps in Post-Approval Change Submissions

Addressing Gaps in Stability Study Design for Post-Approval Changes In the dynamic landscape of pharmaceutical development, maintaining the integrity of stability studies after a product’s market approval can be challenging.…

How to Support Drug Product Expiry with Statistical Stability Data

Implementing Statistical Stability Data to Support Drug Product Expiry In the pharmaceutical industry, ensuring drug product efficacy throughout its shelf life is paramount. One of the critical activities in achieving…

How to Conduct Forced Photodegradation Before Formal Photostability Studies

Conducting Forced Photodegradation to Prevent Photostability Study Failures Photostability study failures can lead to significant setbacks in pharmaceutical development and regulatory approval. Understanding the nuances of forced photodegradation and its…

Why Annual Stability Batches Fail to Prove Continued Control

Addressing Failures in Annual Stability Batches and Maintaining Control The pharmaceutical manufacturing industry faces numerous challenges in ensuring the reliability and accuracy of stability studies. One common but critical issue…

Regulatory Expectations for Retest Periods of APIs

Addressing Challenges in Complying with Regulatory Expectations for Retest Periods of APIs The requirement for establishing stability profiles for Active Pharmaceutical Ingredients (APIs) can often lead to challenges in maintaining…

Photostability Failure in Semi-Solid Products: Causes and Controls

Addressing Photostability Failures in Semi-Solid Pharmaceutical Products Photostability failures in semi-solid pharmaceutical products pose significant challenges for manufacturers and quality assurance professionals. When these products exhibit instability upon exposure to…

Photostability Failure in Semi-Solid Products: Causes and Controls

Addressing Photostability Issues in Semi-Solid Pharmaceutical Products Photostability failures, particularly in semi-solid pharmaceutical products, pose a significant challenge to manufacturers. These failures can lead to compromised product quality, shorter shelf…

Stability Study Design Mistakes in Ongoing Stability Programs

Common Pitfalls in Stability Study Design within Ongoing Stability Programs Stability study design errors can significantly impact the integrity of data supporting a pharmaceutical product’s shelf life. As professionals working…

Stability Study Design Mistakes in Ongoing Stability Programs

Common Pitfalls in Stability Study Design and Effective Solutions In the high-stakes world of pharmaceutical development, the integrity of stability studies is paramount. Stability study design errors can have cascading…